肠道微生物组：连接干细胞移植后的药物使用与临床预后
The gut microbiome: Bridging medications and clinical outcomes post stem cell transplantation.
发表日期：2023 Aug 09
作者：
Ziyu Huang, Tao Zuo
来源：
Cell Host & Microbe
摘要：
细胞和微生物宿主上，Nguyen等人和Vallet等人最近分别发表的文章中，揭示了异基因造血干细胞移植后，肠道菌群动态对临床结果的影响。这些研究对解析药物在抗癌治疗中的作用深有裨益。版权所有 © 2023 Elsevier Inc. 保留所有权利。
Anti-cancer therapies are usually intertwined with prolonged use of drugs, which may lead to different clinical outcomes. Recently in Cell and Cell Host & Microbe, Nguyen et al. and Vallet et al., respectively, deconvolute the drug effects on gut microbiome dynamics underpinning clinical outcomes after allogeneic hematopoietic stem cell transplantation.Copyright © 2023 Elsevier Inc. All rights reserved.